Related Experiment Video
Updated: Aug 23, 2026

Quantitative Detection of DNA-Protein Crosslinks and Their Post-Translational Modifications
Published on: April 21, 2023
Development of DNA topoisomerase-related therapeutics: a short perspective of new challenges
Giovanni Capranico1, Giuseppe Zagotto, Manlio Palumbo
1Department of Biochemistry G. Moruzzi, Alma Mater Studiorum University of Bologna, via Irnerio 48, 40126 Bologna, Italy. giovanni.capranico@unibo.it
Abstract:
Antitumor agents targeting DNA and DNA-associated processes are widely used in the treatment of human cancers and produce significant increases in the survival of patients. DNA topoisomerases remain the most significant target of these cytotoxic drugs and constitute a growing family of nuclear enzymes that regulate DNA topology during DNA replication and recombination, DNA transcription, chromosome condensation-decondensation and segregation. Major progress has been attained in recent years in the understanding of the structures of these enzymes and their main cellular functions, hopefully providing new opportunities for pharmacological interventions. New leads and derivatives of known structures have been reported recently, and here they will be discussed highlighting the challenges to find innovative and more effective drugs. Moreover, we will review novel and diverse approaches relevant to the development of new topoisomerase-related therapeutics.
Insights
DNA topoisomerases are crucial targets for antitumor drugs, enhancing cancer patient survival. Recent research explores new drug leads and diverse approaches to develop more effective topoisomerase-related cancer therapeutics.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Antitumor agents targeting DNA and DNA-associated processes are vital in cancer treatment.
- DNA topoisomerases are key nuclear enzymes regulating DNA topology during essential cellular processes.
- These enzymes are significant targets for cytotoxic anticancer drugs.
Purpose of the Study:
- To review recent advancements in understanding DNA topoisomerase structures and functions.
- To discuss new drug leads and derivatives targeting DNA topoisomerases.
- To explore novel approaches for developing innovative topoisomerase-related therapeutics.
Main Methods:
- Literature review of recent studies on DNA topoisomerases.
- Analysis of novel drug candidates and derivatives.
- Discussion of emerging therapeutic strategies.
Main Results:
- Significant progress has been made in understanding topoisomerase structure and function.
- New drug leads and derivatives targeting topoisomerases have been identified.
- Diverse novel approaches for topoisomerase-related drug development are emerging.
Conclusions:
- DNA topoisomerases remain critical targets for anticancer drug development.
- Continued research into topoisomerase structure and function offers new pharmacological intervention opportunities.
- Developing innovative and more effective topoisomerase-targeting drugs presents ongoing challenges and opportunities.
Related Concept Videos
DNA Topoisomerases
Types and Mechanism of action
Topoisomerases are divided into two main types. Type I...
Inhibitors of Bacterial DNA Synthesis
DNA Helicases
The Replisome
The synthesis of the leading and lagging strands is a highly coordinated process. To explain this, the “Trombone model” was proposed by Bruce Alberts in 1980. The DNA loop formation starts when a primer is synthesized on the parent lagging strand. The loop grows with the...
The DNA Replication Fork
The DNA Replication Fork

